ATE123783T1 - Ribonukleotidreduktase-hemmer. - Google Patents
Ribonukleotidreduktase-hemmer.Info
- Publication number
- ATE123783T1 ATE123783T1 AT90102453T AT90102453T ATE123783T1 AT E123783 T1 ATE123783 T1 AT E123783T1 AT 90102453 T AT90102453 T AT 90102453T AT 90102453 T AT90102453 T AT 90102453T AT E123783 T1 ATE123783 T1 AT E123783T1
- Authority
- AT
- Austria
- Prior art keywords
- amino
- phe
- decapeptide
- tyr
- radical
- Prior art date
Links
- 229940127395 Ribonucleotide Reductase Inhibitors Drugs 0.000 title 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 abstract 4
- 125000000539 amino acid group Chemical group 0.000 abstract 3
- 125000001589 carboacyl group Chemical group 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 235000019260 propionic acid Nutrition 0.000 abstract 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 abstract 2
- ORQXBVXKBGUSBA-UHFFFAOYSA-N 2-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)C(N)CC1CCCCC1 ORQXBVXKBGUSBA-UHFFFAOYSA-N 0.000 abstract 1
- 102000000505 Ribonucleotide Reductases Human genes 0.000 abstract 1
- 108010041388 Ribonucleotide Reductases Proteins 0.000 abstract 1
- 230000002159 abnormal effect Effects 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical group 0.000 abstract 1
- 230000004663 cell proliferation Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- -1 hydroxy, amino Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA000591372A CA1327869C (en) | 1989-02-17 | 1989-02-17 | Ribonucleotide reductase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE123783T1 true ATE123783T1 (de) | 1995-06-15 |
Family
ID=4139636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90102453T ATE123783T1 (de) | 1989-02-17 | 1990-02-08 | Ribonukleotidreduktase-hemmer. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5071835A (de) |
| EP (1) | EP0383190B1 (de) |
| JP (1) | JPH02264796A (de) |
| AT (1) | ATE123783T1 (de) |
| AU (1) | AU633543B2 (de) |
| CA (1) | CA1327869C (de) |
| DE (1) | DE69020002T2 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU643636B2 (en) * | 1989-07-07 | 1993-11-18 | Bio-Mega/Boehringer Ingelheim Research Inc. | Antiherpes pentapeptide derivatives having a substituted aspartic acid side chain |
| ATE123294T1 (de) * | 1989-07-07 | 1995-06-15 | Bio Mega Boehringer Ingelheim | Antiherpes-tetrapeptid-derivate mit einer substituierten seitenkette aus asparaginsäure. |
| WO1992013549A1 (en) * | 1991-02-07 | 1992-08-20 | Research Corporation Technologies, Inc. | Inhibition of cell proliferation by hydrophobic peptides |
| US5459063A (en) * | 1993-10-14 | 1995-10-17 | The University Of Pennsylvania | Plasmodium falciparum ribonucleotide reductase DNA |
| CA2259123C (en) * | 1996-07-01 | 2003-10-21 | Jim A. Wright | Oligonucleotides from the untranslated regions of ribonucleotide reductase and their use to modulate cell growth |
| US6593305B1 (en) | 1996-08-02 | 2003-07-15 | Genesense Technologies Inc. | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| AU2004209579B2 (en) | 2003-02-10 | 2010-03-04 | Lorus Therapeutics Inc. | Antisense oligonucleotides directed to ribonucleotide reductase R2 and uses thereof in the treatment of cancer |
| US8029815B2 (en) * | 2004-04-28 | 2011-10-04 | Elford Howard L | Methods for treating or preventing restenosis and other vascular proliferative disorders |
| JP5128277B2 (ja) * | 2004-05-28 | 2013-01-23 | ユニジェン・インコーポレーテッド | 二核酵素の強力な阻害剤としてのジアリールアルカン類 |
| EP2030615A3 (de) * | 2007-08-13 | 2009-12-02 | ELFORD, Howard L. | Ribonukleotidreduktase-Inhibitoren zur Verwendung für die Behandlung oder Vorbeugung von Nervenentzündung- oder Autoimmunerkrankungen |
| KR102107460B1 (ko) | 2008-07-21 | 2020-05-08 | 유니젠, 인크. | 일련의 피부-화이트닝(라이트닝) 화합물 |
| KR102113823B1 (ko) | 2011-03-24 | 2020-05-21 | 유니젠, 인크. | 디아릴프로판의 제조를 위한 화합물 및 방법 |
| WO2025240847A1 (en) | 2024-05-17 | 2025-11-20 | Revolution Medicines, Inc. | Ras inhibitors |
| US20250375445A1 (en) | 2024-06-07 | 2025-12-11 | Revolution Medicines, Inc. | Methods of treating a ras protein-related disease or disorder |
| WO2025265060A1 (en) | 2024-06-21 | 2025-12-26 | Revolution Medicines, Inc. | Therapeutic compositions and methods for managing treatment-related effects |
| WO2026006747A1 (en) | 2024-06-28 | 2026-01-02 | Revolution Medicines, Inc. | Ras inhibitors |
| WO2026015790A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015801A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
| WO2026015825A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Use of ras inhibitor for treating pancreatic cancer |
| WO2026015796A1 (en) | 2024-07-12 | 2026-01-15 | Revolution Medicines, Inc. | Methods of treating a ras related disease or disorder |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4448730A (en) * | 1981-03-24 | 1984-05-15 | Riet Bartholomeus Van T | Hydroxybenzohydroxamic acids, benzamides and esters and related compounds as ribonucleotide reductase inhibitors |
| US4795740A (en) * | 1986-05-20 | 1989-01-03 | Cohen Eric A | Antiviral peptides and means for treating herpes infections |
| US4845195A (en) * | 1987-05-22 | 1989-07-04 | Merck & Co., Inc. | Inhibitor of ribonucleotide reductase |
| US4837304A (en) * | 1987-05-22 | 1989-06-06 | Merck & Co., Inc. | Inhibitor of ribonucleotide reductase |
| US4814432A (en) * | 1987-05-22 | 1989-03-21 | Merck & Co., Inc. | Inhibitor of ribonucleotide reductase |
-
1989
- 1989-02-17 CA CA000591372A patent/CA1327869C/en not_active Expired - Fee Related
-
1990
- 1990-02-01 US US07/474,589 patent/US5071835A/en not_active Expired - Lifetime
- 1990-02-08 AT AT90102453T patent/ATE123783T1/de active
- 1990-02-08 EP EP90102453A patent/EP0383190B1/de not_active Expired - Lifetime
- 1990-02-08 DE DE69020002T patent/DE69020002T2/de not_active Expired - Fee Related
- 1990-02-16 JP JP2035987A patent/JPH02264796A/ja active Pending
- 1990-02-16 AU AU49867/90A patent/AU633543B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU633543B2 (en) | 1993-02-04 |
| EP0383190B1 (de) | 1995-06-14 |
| JPH02264796A (ja) | 1990-10-29 |
| DE69020002D1 (de) | 1995-07-20 |
| DE69020002T2 (de) | 1995-12-14 |
| CA1327869C (en) | 1994-03-15 |
| EP0383190A3 (de) | 1991-11-21 |
| EP0383190A2 (de) | 1990-08-22 |
| AU4986790A (en) | 1990-08-23 |
| US5071835A (en) | 1991-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE123783T1 (de) | Ribonukleotidreduktase-hemmer. | |
| NZ296479A (en) | Amino acid or peptide derivatives which are inhibitors of multicatalytic protease (mcp) | |
| AU5222498A (en) | Type i recombinant clostridium histolyticum collagenase and its use for isolating cells and cell aggregates | |
| MY137301A (en) | Peptide analogs as irreversible interleukin-1b protease inhibitors | |
| MY120693A (en) | Human bikunin | |
| TW215441B (de) | ||
| RU94045952A (ru) | Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена | |
| DK0387231T3 (da) | Hidtil ukendte inhibitorer for retroviral protease | |
| GR860399B (en) | Process for obtaining peptidic derivatives pepstatine analogs renines inhibitors and proteases acids | |
| Doebber et al. | Identification of a tripeptidyl aminopeptidase in the anterior pituitary gland: effect on the chemical and biological properties of rat and bovine growth hormones | |
| NZ336793A (en) | Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture | |
| EP0498784A3 (en) | Inhibitors of retroviral protease | |
| NO971621L (no) | Keratinocyttvekstfaktoranaloger | |
| Darlak et al. | Thiol-based inhibitors of mammalian collagenase. Substituted amide and peptide derivatives of the leucine analogue, 2-[(R, S)-mercaptomethyl]-4-methylpentanoic acid. | |
| NZ335879A (en) | Somatostatin antagonist peptides having a D-amino acid at the second residue | |
| DE3782880D1 (de) | Hemmende peptide. | |
| NZ320932A (en) | Short forms of chemokine b-8 | |
| EP0204328A3 (en) | Novel thf compositions | |
| NZ511747A (en) | Regulatory/unfolding peptides of ezrin | |
| NO963255L (no) | Sykliske neurokinin-A antagonister | |
| SE8703855L (sv) | Vasoaktiva peptider | |
| Hemmasi et al. | THE SOLID‐PHASE SYNTHESIS OF α‐MELANOTROPIN HYDRAZIDE | |
| JPS55129253A (en) | Psychopharmacologically active peptide | |
| NO901771L (no) | Renin-inhibitorer inneholdende en (1-amino-2-hydroksy-2-heterocyklisk)-etylrest. | |
| AR009422A1 (es) | Analogos peptidos lh-rh, su empleo y composiciones farmaceuticas en las cuales estan presentes |